Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-01 Gift | 2021-04-19 8:04 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 21,254 | $0 | 0 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-19 8:04 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 66,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 8:04 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 170,263 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 8:04 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 412,682 | $0 | 0 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-19 7:57 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 66,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:57 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 138,947 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:57 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 365,000 | $0 | 0 (Direct) | View |
| 2021-03-31 Gift | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 8,085 | $0 | 0 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 66,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 135,547 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 368,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:49 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 33,423 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:49 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 55,000 | $0 | 0 (Direct) | View |
| 2021-04-05 Gift | 2021-04-19 7:46 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 10,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:46 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 404,452 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 5,000 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BERGER FRANKLIN M Director | 67,500 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:39 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Dhingra Kapil Director | 80,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:35 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Jensen Peder Director | 80,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:32 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Nicholson Garry A Director | 60,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:28 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | SCHAFER CAROL Director | 46,250 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Lyons-Williams Lori Director | 45,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:21 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 68,971 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:21 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 480,000 | $0 | 0 (Direct) | View |
| 2021-04-09 Tax Withholding | 2021-04-13 1:05 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 11,088 | $37.94 | 68,971 (Direct) | View |
Ownership | 2021-03-08 4:58 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 6,262,085 (Direct) | View |
| 2021-02-26 Tax Withholding | 2021-03-02 12:16 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 1,158 | $22.23 | 123,433 (Direct) | View |
| 2021-02-26 Tax Withholding | 2021-03-02 12:08 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,158 | $22.23 | 77,632 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 1,461 | $22.23 | 33,423 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 2:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 1,653 | $23.08 | 124,591 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:42 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 5,100 | $25.71 | 124,591 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 2:36 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,653 | $23.08 | 78,790 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:36 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 5,091 | $25.71 | 78,790 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:31 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 5,110 | $25.71 | 72,947 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:26 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 1,155 | $25.71 | 34,884 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:19 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 22,000 | $0 | 126,427 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:19 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 11,583 | $16.14 | 126,427 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:09 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 22,000 | $0 | 78,057 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:09 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 11,504 | $16.14 | 78,057 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 22,000 | $0 | 85,534 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 11,583 | $16.14 | 85,534 (Direct) | View |
| 2020-11-26 Tax Withholding | 2020-11-30 2:49 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 6,920 | $18.45 | 67,561 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:38 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 22,000 | $0 | 138,010 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:38 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Sarena Francis Willard Chief Strategy Officer | 11,001 | $18 | 138,010 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:29 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 22,000 | $0 | 96,481 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:29 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Smith David V Executive Vice President & CFO | 10,908 | $18 | 96,481 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 22,000 | $0 | 97,117 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 11,039 | $18 | 97,117 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:17 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 26,000 | $2.8 | 62,408 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:17 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 52,959 | $2.22 | 62,408 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:17 pm | N/A 2030-03-18 | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 78,959 | $0 | 62,408 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 1:51 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | White David See Remarks | 6,916 | $4.7 | 36,039 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 1:46 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 827 | $4.69 | 64,156 (Direct) | View |
| 2020-05-19 Option Award | 2020-05-20 4:14 pm | N/A 2030-05-18 | FIVE PRIME THERAPEUTICS INC. | FPRX | RINGO WILLIAM R Director | 27,769 | $0 | 27,769 (Direct) | View |
Ownership | 2020-05-18 7:51 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | BVF GP HOLDINGS LLC BVF I GP LLC BVF II GP LLC 10% Owner | 0 | $0 | 7,008,781 (Indirect) | View |
| 2020-05-14 Option Award | 2020-05-18 10:36 am | N/A 2030-05-13 | FIVE PRIME THERAPEUTICS INC. | FPRX | Jensen Peder Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 5:49 pm | N/A 2030-05-13 | FIVE PRIME THERAPEUTICS INC. | FPRX | Nicholson Garry A Director | 20,000 | $0 | 20,000 (Direct) | View |